IntuitionLabs
Calyx eClinical consulting and implementation services for pharma sponsors and CROs

Calyx eClinical Consulting, Integration & AI Enablement

Validated Calyx EDC, IRT/RTSM, Medical Imaging, and Regulatory deployment, integration, and AI enablement for pharma sponsors, CROs, and biotechs running global clinical trials.

Our Calyx Services

We help sponsors and CROs extract maximum value from the Calyx eClinical Suite — from first study build and protocol activation through cross-platform integration, AI-augmented monitoring, and inspection-ready validation operations.

AI Innovation
AI Integration
Connect Claude, GPT, and Gemini to Calyx EDC, IRT, and Imaging via REST APIs. Build validated AI workflows for MedDRA coding, data anomaly detection, supply forecasting, and natural-language data review.
Explore AI integration
Compliance
GxP Validation
Validate Calyx EDC, IRT, and Imaging for 21 CFR Part 11, EU Annex 11, ICH E6(R3), and GAMP 5 Category 4 compliance. Risk-based study build validation, periodic review, and continuous-release regression testing.
View validation services
Implementation
Study Build & Integration
End-to-end Calyx study build including eCRF design (CDASH/SDTM-aligned), edit-check programming, IRT supply strategy, randomization, imaging charter setup, and integration with Veeva, safety, CTMS, and ERP systems.
Plan your study

A Tier-1 eClinical Suite for Complex Global Trials

Calyx is the eClinical heritage of Parexel combined with the imaging and IRT depth of legacy Perceptive Informatics — and remains one of the three dominant platforms used in pivotal oncology, ophthalmology, neurology, and rare disease trials worldwide. Validated for 21 CFR Part 11, EU Annex 11, and ICH E6(R3) GCP, Calyx is designed for the scale, complexity, and global regulatory exposure that pharma sponsors face on pivotal programs.

Calyx eClinical Suite dashboard showing global Phase III oncology trial across multiple regions

Built for Oncology, Imaging, and Adaptive Designs

Calyx is the platform of choice for trials where central imaging, complex blinding, or adaptive randomization make off-the-shelf eClinical insufficient. The Calyx Medical Imaging platform handles DICOM ingestion, anonymization, blinded independent central review (BICR), and adjudication workflows aligned to RECIST 1.1, iRECIST, Lugano, and ophthalmology endpoint frameworks. Calyx IRT handles randomization, depot management, expiry, and double-blind double-dummy supply across hundreds of sites and dozens of countries — all under the supply-chain expectations of EU GMP Annex 13.

Calyx Medical Imaging adjudication workflow for oncology RECIST endpoints

Integrated Across the Clinical & Safety Stack

Calyx exposes REST APIs and ODM-XML, SDTM, and E2B exports for tight integration across the clinical trial stack. We routinely connect Calyx EDC to Veeva Vault CDB or Medidata Clinical Data Studio for centralized data review; to Oracle Argus or ArisGlobal LifeSphere Safety for SAE reconciliation via ICH E2B(R3); to Veeva Vault CTMS and eTMF; and to ERP systems for clinical supply finance and depot management.

Calyx integrations with Veeva, Medidata, Argus, CTMS, and ERP systems

What We Deliver With Calyx

Our Calyx practice covers the full study lifecycle — first-time platform deployment, study-by-study build and validation, integration with the surrounding clinical stack, AI-enabled monitoring, and inspection-ready operations.

Study Build & eCRF Design

Protocol-to-CRF mapping with CDASH conventions, edit-check programming, derivation rules, dynamic visit scheduling, and SDTM-ready CRF libraries. We deliver Calyx EDC study builds tuned for clean database lock and submission-ready datasets.

Plan study build

IRT / RTSM & Supply

Calyx IRT randomization design (stratified, minimization, adaptive), drug supply forecasting, depot configuration, expiry and resupply rules, and integration with 3PL and depot management systems for global cold-chain investigational products.

Discuss IRT

Medical Imaging Setup

Calyx Medical Imaging charter and read manual development, RECIST/iRECIST/Lugano configuration, adjudicator workflow setup, BICR site training, and endpoint reconciliation back into Calyx EDC for time-to-event analyses.

Imaging consulting

Integration Engineering

Validated integrations between Calyx and Veeva Vault CDB/CTMS/eTMF, Medidata Clinical Data Studio, Oracle Argus, ArisGlobal LifeSphere, SAP, and 3PL depot systems. We use MuleSoft, Boomi, and Workato with full GxP validation packages.

Integration approach

GxP Validation

Validate Calyx EDC, IRT, and Imaging as GAMP 5 Category 4 configured products. URS, configuration specification, FMEA risk assessment, IQ/OQ/PQ protocols, traceability matrices, periodic review SOPs, and audit-ready documentation packs.

Validation services

AI-Augmented Monitoring

Connect Claude, GPT, and Gemini to Calyx via REST API. Build validated workflows for MedDRA/WHODrug coding suggestions, eCRF anomaly detection, central monitoring signals, supply forecasting, and SAE narrative drafting — all within your GxP framework.

AI integration

Why Choose IntuitionLabs for Calyx

We are not a generic eClinical integrator with a clinical playbook. IntuitionLabs combines deep clinical operations and biostatistics fluency with API engineering, AI integration, and GAMP 5 validation under one roof — the combination that lets sponsors run more efficient trials without sacrificing inspection readiness.

Clinical-Stack Depth

Our team operates fluently across Calyx, Medidata, Veeva Vault CDB, Oracle InForm, and Castor EDC — and tells you when each is the right fit.

CDISC-Native Build

We design eCRFs that are CDASH-aligned and SDTM-ready from day one, eliminating expensive remapping during submission prep.

AI + GxP Validation

AI workflows that run with full audit trail and human-in-the-loop sign-off, aligned to FDA AI in drug development guidance.

Calyx Integration Ecosystem

🔗

Calyx EDC + Veeva / Medidata Data Hubs

Stream Calyx EDC data to Veeva Vault CDB or Medidata Clinical Data Studio for centralized data review, cross-source reconciliation, and risk-based monitoring dashboards across sponsor and CRO data feeds.

🛡️

Calyx + Argus / LifeSphere Safety

Automated SAE reconciliation between Calyx EDC and Oracle Argus or ArisGlobal LifeSphere Safety using ICH E2B(R3) standards. Two-way query workflows ensure case-level and CRF-level consistency for inspection.

🚚

Calyx IRT + ERP / 3PL Depot

IRT-driven drug shipment requests flow to SAP S/4HANA or 3PL depot WMS systems for cold-chain dispatch, expiry tracking, and global supply forecasting under EU GMP Annex 13 expectations.

🩻

Calyx Medical Imaging + EDC

Adjudicated endpoint reads flow from Calyx Medical Imaging into the Calyx EDC database for time-to-event analyses, RECIST/iRECIST progression flags, and BICR-vs-investigator concordance reporting.

📱

Calyx + ePRO / eCOA

Bidirectional integration with Medidata Patient Cloud, Clario eCOA, and other ePRO vendors so patient-reported outcomes appear inline with site-collected eCRF data for medical monitoring and central review.

🤖

Calyx + AI Models

Claude, GPT, and Gemini connected to Calyx via REST API for MedDRA/WHODrug coding, data anomaly detection, supply forecasting, and natural-language data review — with full audit trail and human-in-the-loop sign-off.

Today's business insights

Profitable growth in the AI solutions industry

Our CEO discusses how AI is transforming the pharmaceutical industry and shares key strategies for leveraging AI in drug discovery and development.

More insights on unlock profitable growth in ai solutions
Profitable growth in the AI solutions industry

Getting Started With Calyx

Every Calyx engagement begins with understanding your protocol, sponsor obligations, and downstream submission strategy — the therapeutic area and endpoint complexity (oncology BICR, ophthalmology OCT, neurology MRI), the regulatory authorities you will file with (FDA, EMA, PMDA, MHRA), the CRO and vendor mix in your operating model, and the data review architecture you intend to operate.

Our team has supported sponsors and CROs across Phase I FIH to Phase III global pivotal programs. We bring the validation expertise, the data engineering chops, and the AI enablement capabilities that turn a Calyx deployment into a genuine clinical operations advantage.

Engagement Models

  • Discovery Workshop — 2-day protocol review and Calyx fit assessment with build estimate
  • Study Build Project — Full Calyx EDC/IRT/Imaging build, validation, integration, and go-live (12–24 weeks)
  • Integration Add-On — Connect Calyx to Veeva, Medidata, Argus, LifeSphere, CTMS, or ERP with validated middleware
  • AI Enablement Add-On — Layer external AI on top of an existing Calyx study for coding, anomaly detection, or narrative drafting
  • Managed Services — Ongoing administration, periodic review, release validation, and inspection support retainer

Frequently Asked Questions

Calyx is one of the most widely deployed eClinical platforms in pharmaceutical and biotech clinical research, formed from the combination of Parexel Informatics and Calyx (formerly Perceptive Informatics). The current product portfolio spans Calyx EDC (electronic data capture for case report forms), Calyx IRT / RTSM (interactive response technology and randomization & trial supply management), Calyx Medical Imaging (centralized imaging for oncology, CNS, ophthalmology and cardiovascular endpoints), and Calyx Regulatory (publishing, submissions and registrations, the former LIQUENT InSight platform). IntuitionLabs helps sponsors, CROs, and biotech study teams stand these systems up, integrate them across the clinical stack, validate them under GAMP 5, and extend them with AI for medical coding, data anomaly detection, and trial supply forecasting.
Calyx EDC competes directly with Medidata Rave, Veeva Vault CDB, Oracle InForm, and Castor EDC. Calyx tends to win in studies that require tight coupling with the broader Parexel ecosystem, complex global multi-site trials, and indications where centralized medical imaging is a primary endpoint (oncology RECIST, ophthalmology, neuroimaging). Medidata Rave dominates in large pharma standardization deals and integrates natively with the broader Medidata Clinical Cloud. Veeva Vault CDB is increasingly chosen by sponsors that have already standardized on Veeva for CTMS, eTMF, and safety. Oracle InForm remains entrenched in late-stage cardiovascular outcomes and pediatric trials. IntuitionLabs is platform-agnostic and helps sponsors choose the right EDC before any contract is signed.
Calyx products expose modern REST-style APIs and message-based interfaces under the Calyx Developer Portal and the Calyx Connect integration framework. Typical endpoints cover subject enrollment events, randomization assignments, drug shipment requests, eCRF data extracts, query workflows, and imaging read status. Calyx also supports standards-based data exchange — CDISC ODM-XML for case report form definitions and data, SDTM for submission-ready datasets, and HL7 FHIR for site EHR connectivity. We design integrations that respect Calyx rate limits, idempotency rules, and audit trail expectations, and we document them as part of a validated configuration package suitable for FDA, EMA, MHRA, and PMDA inspection.
Common Calyx integrations we deliver include Calyx EDC → Veeva Vault CDB or Medidata Clinical Data Studio for centralized data review; Calyx EDC → Oracle Argus or ArisGlobal LifeSphere Safety for SAE reconciliation per the ICH E2B(R3) standard; Calyx IRT → SAP S/4HANA or ERP-of-record for drug shipment, depot inventory, and cold-chain expiry tracking; Calyx CTMS adapters with Veeva Vault CTMS and Medidata CTMS for visit windows and site activation milestones; Calyx eTMF integration with Veeva Vault eTMF using the TMF Reference Model; and Calyx Medical Imaging into the broader trial master file for endpoint adjudication records. We use iPaaS platforms such as MuleSoft, Boomi, and Workato, all with full computer system validation packages.
Yes. Calyx products implement the technical controls required by 21 CFR Part 11, EU Annex 11, and ICH E6(R3) Good Clinical Practice — Part 11–compliant electronic signatures, immutable audit trails on every CRF field, role-based access, password policy enforcement, and validated platform releases. Compliance is a shared responsibility model: Calyx attests to platform validation; the sponsor is accountable for validated study build, controlled change management, periodic review, and supplier qualification of Calyx itself. IntuitionLabs delivers the user-side artifacts that turn vendor capability into inspection-ready operations — see our Calyx compliance & validation services.
A first-time Calyx EDC study build for a Phase II oncology protocol typically runs 12–16 weeks: protocol-to-CRF mapping (2–3 weeks), eCRF design and edit-check programming in Calyx Form Builder (3–4 weeks), Calyx IRT supply strategy and randomization list generation (2 weeks), integration build with safety database and CTMS (3–4 weeks), user acceptance testing and validation execution (2–3 weeks), and study go-live with site activation. A simple Phase I single-site study can compress to 6–8 weeks, while a complex global Phase III with adaptive randomization, central imaging, and ePRO integration can reach 24–32 weeks. IntuitionLabs accelerates delivery using pre-built CDISC-aligned CRF libraries and reusable edit-check patterns aligned to CDASH conventions.
Calyx EDC supports CDISC standards at every layer of the data pipeline. CRF design follows CDASH conventions so collected data maps cleanly to SDTM domains for submission. ODM-XML exports support data transfer to downstream review and statistical computing environments (SAS, R, Medidata Clinical Data Studio, eClinical Solutions elluminate). For submissions to FDA and PMDA, programmer teams use ADaM-conformant analysis datasets generated from the SDTM layer. We help sponsors design Calyx CRFs that are SDTM-ready from day one — eliminating expensive remapping during database lock and submission preparation. CDISC compliance also satisfies the FDA Study Data Standards mandate.
Yes — Calyx has invested heavily in decentralized clinical trial (DCT) capabilities. Calyx EDC supports remote source data verification (rSDV) workflows where monitors review source documents uploaded by sites or imported from EHR systems; Calyx IRT supports direct-to-patient drug shipment with cold-chain monitoring and home-health visit scheduling; and the Calyx eClinical Suite integrates with ePRO/eCOA vendors and televisit platforms. The FDA September 2024 final guidance on Decentralized Clinical Trials and the corresponding EMA recommendation paper on decentralised elements set the regulatory framework we implement against. IntuitionLabs builds the integration scaffolding (FHIR-based EHR data ingestion, ePRO connectivity, eConsent workflows) that turns Calyx into a hybrid-trial platform.
Calyx Medical Imaging is a centralized medical imaging platform used in trials where imaging is a primary or key secondary endpoint — including oncology (RECIST 1.1, iRECIST, Lugano), ophthalmology (OCT, fundus photography), neurology (MRI volumetrics, amyloid PET), and cardiovascular outcomes. The platform handles DICOM ingestion from sites worldwide, anonymization, central read assignment, adjudicator workflows, charter and read manual management, and statistical export. Studies with subjective endpoints, regulatory expectations for blinded independent central review (BICR), or geographically distributed reader panels almost always require a platform of this class — and Calyx (with BioClinica/Clario and ICON Medical Imaging) is one of the three dominant vendors. We integrate Calyx Medical Imaging endpoint data back into EDC for adjudicated endpoint flags and time-to-event analyses.
Calyx IRT (formerly ClinPhone) supports a wide range of randomization schemes — simple, stratified, block, adaptive, minimization, response-adaptive — and integrates randomization with trial supply forecasting, depot management, expiry tracking, and shipment automation. The system supports complex blinding scenarios (double-blind, double-dummy, sponsor unblinded pharmacist) required by sophisticated pharma trials and operates under the supply guidance frameworks in ICH Q7 and EU GMP Annex 13. For sponsors juggling multiple cold-chain investigational products across hundreds of sites in 30+ countries, Calyx IRT is one of the few mature systems that can model and execute the full supply chain. IntuitionLabs configures IRT studies, integrates with depots and 3PLs, and validates the full supply pathway.
Calyx is classified as a GAMP 5 Category 4 configured product. Validation focuses on configuration verification — eCRF designs, edit checks, randomization lists, IRT supply rules, integration interfaces, and user role configurations — rather than re-testing platform code that Calyx has already validated. The typical validation artifact package includes URS, configuration specification, FMEA-based risk assessment, IQ/OQ/PQ protocols and reports, requirements-to-test traceability matrix, validation summary report, and a periodic review SOP. Calyx releases platform updates on a continuous-deployment cadence, so we use risk-based regression test suites and DevOps automation to keep customer studies validated through every vendor release. See our Calyx validation services for full detail.
There are several high-value AI workflows we deliver on top of Calyx data. First, automated MedDRA and WHODrug medical coding suggestions for adverse events and concomitant medications — using validated Claude or OpenAI models with human review and audit trail. Second, anomaly detection on incoming eCRF data, flagging implausible values, digit-preference patterns, and site-level fraud signals as a complement to TransCelerate risk-based quality management. Third, trial supply forecasting that pulls from Calyx IRT shipment history, depot inventory, and predicted enrollment to recommend resupply timing. Fourth, automated narrative writing for serious adverse events drawing from Calyx EDC and Calyx-connected safety systems. All of these run with full audit trail, human-in-the-loop sign-off, and validation per FDA January 2025 draft guidance on AI in drug development. See our Calyx AI integration services.
Calyx is used by large and mid-size pharmaceutical sponsors, biotechs running complex Phase II/III trials, and most major CROs — including Parexel (Calyx's heritage parent), IQVIA, ICON, Thermo Fisher PPD, and Syneos Health (now part of Syneos). The platform is particularly strong in oncology, rare disease, ophthalmology, and CNS — therapeutic areas where central imaging, adaptive randomization, and complex blinding are common. For emerging biotechs running their first pivotal trial, IntuitionLabs helps evaluate whether Calyx, Medidata, or Veeva Vault CDB is the right fit given the protocol, sponsor obligations, and downstream submission strategy.
After study go-live, the work shifts to operations: maintaining controlled change management as protocol amendments roll out, executing periodic reviews, validating Calyx platform releases against your study configurations, optimizing edit-check libraries, and supporting database lock and CSR delivery. IntuitionLabs offers tiered managed services covering Calyx administration retainers, validation-on-demand for new studies or protocol amendments, periodic review execution, and inspection readiness support during FDA BIMO inspections or EMA GCP inspections. See our full managed services offering.
Ready to Run Better Clinical Trials?
Ready to Run Better Clinical Trials? image

Ready to Run Better Clinical Trials?

Book a discovery session to explore how Calyx — extended with AI-augmented monitoring and CDISC-native study build — can accelerate your pivotal program from FPI to database lock and submission.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.

Privacy PolicyTerms of ServiceBook Meeting